Novel 1, 1-dimethyl-3-phenyl-3-(5-phenyl-1, 3, 4- thiadiazol-2-yl) urea derivative has potential antiproliferative activity against human leukemia cell lines - K562

Khemkaran Ahirwar; Sanmati K. Jain; Bholenath Tamrakar

Authors

Khemkaran Ahirwar Columbia Institute of Pharmacy, Vill. Tekari, Near Vidhan Sabha, Raipur (CG) 493111
Sanmati K Jain SLTIOP, Guru Ghasidas University, Bilaspur, (C.G)
Bholenath Tamrakar Columbia Institute of Pharmacy, Vill. Tekari, Near Vidhan Sabha, Raipur (CG) 493111

Keywords:

Cancer, urea derivative, antiproliferative activities, malignant behavior

Abstract

Cancer is thought to be caused by the interaction between genetic susceptibility and environmental toxins. Based on the DNA changes in cells, proliferating cycle of tumor cells can be divided into 4 phases. Pre-synthetic phase (Gap 1 phase or G1 phase). Cells chiefly make preparations for the synthesis of DNA. Synthetic phase (S phase). Cells are synthesizing their DNA. Post-synthetic phase (Gap 2 phases or G2 phase). DNA duplication has been finished and they are equally divided to the two of future sub-cells. Mitosis phase (M Phase). Each cell is divided into two sub-cells. Some of these new cells enter the new proliferating cycle, the others become non-proliferating cells. G0 phase cells have proliferation ability but do not divide temporally. When proliferating cells are suffered heavy casualties, G0 phase cells will get into proliferating cycle and become the reasons of tumor recurrence.G0 phase cells are usually not sensitive to antineoplastic drugs, which is the important obstacle to tumor.chemotherapy. The antiproliferative activities of these compounds wee evaluated against a Cytotoxicity analysis of compounds against leukemia cell line -K562 organism homo sapiens(human) organ bone – marrow, tissue - lymphoblast, disease – chronic myelogenous leukemia(CML) one human tumor cell lines(K562) by applying the MTT colorimetric assay. The 1, 3-disubstituted urea derivatives show good antiproliferative activity against human cancer cell lines (K562). The hydroxyl groups on the phenyl ring reduced the antiproliferative activities.

Downloads

Download data is not yet available.

References

Hirsch J. "An anniversary for cancer chemotherapy". JAMA 296, (September 2006) volume – 12, Page No.1518–1520

Hirsch J. "An anniversary for cancer chemotherapy". JAMA 296, (September 2006).volume – 12, Page No.1518–1520

Knudson AG (November 2001). "Two genetic hits (more or less) to cancer". Nature reviews. Cancer 1 (2): 157–62

Gurney JG, Smith MA, Ross JA (1999). "Cancer among infants". in Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds). Cancer Incidence and Survival among Children and Adolescents, United States SEER program 1975–1995. Bethesda, MD: National Cancer Institute, SEER Program. pp. 149–56.

Rheingold, Susan; Neugut, Alfred; Meadows, Anna (2003). "156: Secondary Cancers: Incidence, Risk Factors, and Management". in Frei, Emil; Kufe, Donald W.; Holland, James F.. Cancer medicine 6. Hamilton, Ont: BC Decker. p. 2399.

Karpozilos A, Pavlidis N (2004). "The treatment of cancer in Greek antiquity". European Journal of Cancer 40 (14): 2033–40.

Marilyn Yalom "A history of the breast" 1997. New York: Alfred A. Knopf. ISBN 0-679-43459-3.

A. Karnofsky CA Cancer J Clin, Mechanism of Action of Anticancer Drugs at a Cellular Level David 1968; 18; 232-234 DOI: 10.3322/canjclin.18.4.232

Ullrich, A.; Schlesinger J. Cell 61, 1990, Page No. 203-212.

Hubbard, S.R.; Till J.H. Annu. Rev. Biochem. 69, 2000, Page No. 373-398

Hayman, M.J.; Enrietto P.J. Cancer Cells 3, 1991, Page No. 302-307.

Dikic I.; S. Giordano, Curr. Opin. Cell Biol. 15, 2003, Page No. 128-135.

Uckun F.M.; Mao C. Curr. Pharm. Des. 10, 2004, Page No. 1083-1091.

Traxler P.; Green J.; Mett, H. Sequin U.; Furet P. J. Med. Chem. 42, 1999, Page No. 1018-1026.

Li, H.Q.; Zhu, T.T.; Yan, T.; Luo, Y.; Zhu Hai. L. Eur. J. Med. Chem. 44, 2009, Page No. 453- 459.

Bhise, S. B.; Nalawade .A. D.; Wadhawa, H. Indian Journal of Biochemistry & Biophysics, 41, 2004, Page No. 273-280.

Gunby, R.H. Anti-Cancer Agents in Medicinal Chemistry, 7, 2007, Page No. 594-611.

Weinberg, R. A. The Biology of Cancer. New York: Garland Science, Taylor & Francis Group, LLC. Page No. 757–759.

.Destro, A.; Ceresoli, G.L.; Falleni, M.; Zucali, P.A.; Morenghi, E.; Bianchi, P. Pellegrini C. Lung Cancer, 51, 2006, Page No. 207-215.

Zhao, Y, Thomas, H.D, Batey, M.A. Cancer Res. 66, 2006, Page No. 5354–5362.

Beato, M.; Chavez, S.; Truss, M. Steroids 61, 1996, Page No. 240–251.

Hammes, S.R.; Proc Natl Acad Sci USA 100, 2003, Page No. 21680–2170.

Sugden, D.; Davidson, K. Pigment Cell Res. 17, 2004, Page No. 454–460.

Carpenter, G.; Cohen , S. J. Biol. Chem. 265, 1990, Page No. 7709–7712

Ward, M.; Marcey, D. Retrieved on 2007-03-06.

Schroder, E. Journal of Leukocyte Biology 75, 2003, Page No. 163-189.

Chung, C.W.; Cooke, R.M. Biochemistry, 34, 1995, Page No. 9307–9314.

Kistler, J.; Stroud, R.M. Biophys. J. 37, 1982, Page No. 371–383.

Wiesmann, C.; de Vos, A.M. Cell Mol Life Sci 58, 2001, Page No. 748–759.

Hayman, M.J.; Enrietto P.J. Cancer Cells 3, 1991, Page No. 302-307.

Dikic I.; S. Giordano, Curr. Opin. Cell Biol. 15, 2003, Page No. 128-135.

James Richard FrommJames R. Mertz,; Enyuan Shang,; Roseann Piantedosi,; Shuanghong Wei,; Debra J. Wolgemuth,; and William S. Blaner. J. Biol. Chem. 1997 272: 11744-11749.

E. Campaigne "Adrien Albert and the Rationalization of Heterocyclic Chemistry" J. Chemical Education 1986, Volume 6, 860. DOI:10.1021/ed063p860.

J Matysiak; A Opolski. Bioorg. Med. Chem., 2006, 14, 4483-4489.

J Matysiak; A Nasulewicz; M Pelczynska; M Switalska; I Jaroszewicz; A Opolski. Eur. J.Med. Chem., 2006, 41, 475-482.

Ananda Kumar, C.S.; Benaka Prasad, S.B.; Vinaya, K.; Chandrappa, S.; Thimmegowda N.R.; Sunil Kumar,Y.C.; Swarup S.;Rangapp, K.S.; Eur. J. Med. Chem. 44, 2009, 1223–1229.

Li, H.Q.; Zhu, T.T.; Yan, T.; Luo, Y.; Zhu Hai. L. Eur. J. Med. Chem. 44, 2009, 453-459.

Mazei, M.; Miele, M.; Nieddu, E.; Barbieri, F.; Bruzzo, C.; Alama, A. Eur. J. Med. Chem. 36, 2001, 915-923.

Nawrocka, W.; Sztuba, B.; Kowalska, M.W.; Liszkiewicz, H.; Wietrzyk, J.; Nasulewicz, A.; Pełczyn´ska, P.; Opolski A. IL Farmaco 59, 2004, 83- 91.

Qing Song, D.; Ming Wang, Y.; Na Du, N.; Ying He, W.; Liang Chen, K.; Fang Wang, W.; Yang, P.; Zong Wu, L.; Bo Zhang, Z.; Dong Jiang, J. Bioorg. & Med. Chem. Letters 19, 2009, 755–758.

Matysiak, J. Eur, J. of Med. Chem., 42, 2007, 940-947.

Matysiak, J.; Opolski, A. Bioorg. & Med. Chem. 14, 2006, 4483-4489.

Zurbonsen, K.; Michel, A.; Bonnet, P. A.; Mathieu, M. N.; Chevillard, C. Gen. Pharmac. 32, 1999, 135–141.